SonoThera
Develops ultrasound-mediated nonviral genetic medicines
$125MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops ultrasound-mediated nonviral genetic medicines
Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions
Pitching RA Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room